Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / EVLO - Evelo Biosciences climbs 22% as Chardan upgrades shares to buy


EVLO - Evelo Biosciences climbs 22% as Chardan upgrades shares to buy

Shares of Evelo Biosciences (EVLO +22.7%) are up this morning after Chardan Capital Markets upgraded the stock from neutral to buy. Analyst Keay Nakae is maintaining the price target at $12 (~36% upside). The company's lead candidate, EDP1815, is in phase 2/3 for COVID-19 and phase 2 for psoriasis. The move comes after the company missed its EPS estimate in its Q3 2021 earnings last week.

For further details see:

Evelo Biosciences climbs 22% as Chardan upgrades shares to buy
Stock Information

Company Name: Evelo Biosciences Inc.
Stock Symbol: EVLO
Market: OTC
Website: evelobio.com

Menu

EVLO EVLO Quote EVLO Short EVLO News EVLO Articles EVLO Message Board
Get EVLO Alerts

News, Short Squeeze, Breakout and More Instantly...